Page 262 - Binder2
P. 262
It will require early wins, visible outcomes, and shared
success.
Because innovation doesn’t scale on science alone.
It scales on belief.
Not Just a Product—A New Model
Edible biologics are not just a new category of therapy.
They are a new model for:
• How we produce drugs
• How we deliver them
• How we engage the immune system
• And how we make care equitable, scalable, and
resilient
The question isn’t whether edible biologics can work.
They already do.
The real question is:
Can we build the ecosystems, the policies, and the trust
that will let them scale?
If the answer is yes, this won’t just be a new chapter in
biotech.
It will be a rewrite.
260
